{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:06:19Z","timestamp":1790885179149,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012229","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000}}],"reference-count":118,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012229.pub2","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T13:55:56Z","timestamp":1519826156000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Ghrelin for the management of cachexia associated with cancer"],"prefix":"10.1002","volume":"2020","author":[{"given":"Mahalaqua Nazli","family":"Khatib","sequence":"additional","affiliation":[{"name":"Division of Evidence Synthesis; School of Epidemiology and Public Health & Department of Physiology; Datta Meghe Institute of Medical Sciences; Wardha India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuraj H","family":"Shankar","sequence":"additional","affiliation":[{"name":"Department of Nutrition; Harvard University; Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Kirubakaran","sequence":"additional","affiliation":[{"name":"Cochrane South Asia, Prof. BV Moses Centre for Evidence-Informed Healthcare and Health Policy; Christian Medical College; Vellore India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Gaidhane","sequence":"additional","affiliation":[{"name":"Department of Community Medicine; Datta Meghe Institute of Medical Sciences; Wardha India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Gaidhane","sequence":"additional","affiliation":[{"name":"Department of Medicine; Datta Meghe Institute of Medical Sciences; Wardha India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padam","family":"Simkhada","sequence":"additional","affiliation":[{"name":"Centre for Public Health; Liverpool John Moores University; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahiruddin","family":"Quazi Syed","sequence":"additional","affiliation":[{"name":"Department of Research and Development (R&D); Division of Evidence Synthesis, School of Epidemiology and Public Health & Department of Community Medicine; Datta Meghe Institute of Medical Sciences; Wardha India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,2,28]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD012229.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/cncr.24917","article-title":"Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study","volume":"116","author":"Lundholm","year":"2010","journal-title":"Cancer"},{"issue":"6","key":"10.1002\/14651858.CD012229.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1210\/jc.2003-031768","article-title":"Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial","volume":"89","author":"Neary","year":"2004","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"10.1002\/14651858.CD012229.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.bjc.6604148","article-title":"Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia\/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study","volume":"98","author":"Strasser","year":"2008","journal-title":"British Journal of Cancer"},{"issue":"4","key":"10.1002\/14651858.CD012229.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1053\/j.gastro.2009.12.058","article-title":"Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study","volume":"138","author":"Adachi","year":"2010","journal-title":"Gastroenterology"},{"issue":"19","key":"10.1002\/14651858.CD012229.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1002\/cncr.27430","article-title":"Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study","volume":"118","author":"Hiura","year":"2012","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0006|cit6","unstructured":"Individual dose-escalated bi-daily subcutaneously (sc) ghrelin in cancer cachexia: a Phase I\/II Study clinicaltrials.gov 2009"},{"issue":"2","key":"10.1002\/14651858.CD012229.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/SLA.0000000000000986","article-title":"Randomized phase II study of the anti-inflammatory effect of ghrelin during the postoperative period of esophagectomy","volume":"262","author":"Takata","year":"2015","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/B978-0-12-381272-8.00026-X","article-title":"Clinical trial of ghrelin synthesis administration for upper GI surgery","volume":"514","author":"Takiguchi","year":"2012","journal-title":"Methods in Enzymology"},{"issue":"1","key":"10.1002\/14651858.CD012229.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.surg.2009.11.026","article-title":"Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction","volume":"148","author":"Yamamoto","year":"2010","journal-title":"Surgery"},{"issue":"8","key":"10.1002\/14651858.CD012229.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/annonc\/mdu085","article-title":"Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force","volume":"25","author":"Aapro","year":"2014","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012229.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s13539-010-0011-5","article-title":"Ghrelin for cachexia","volume":"1","author":"Akamizu","year":"2010","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"issue":"1","key":"10.1002\/14651858.CD012229.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11912-017-0562-0","article-title":"Update on management of cancer-related cachexia","volume":"19","author":"Anderson","year":"2017","journal-title":"Current Oncology Reports"},{"issue":"1","key":"10.1002\/14651858.CD012229.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1517\/14712598.2013.727390","article-title":"The potential of ghrelin in the treatment of cancer cachexia","volume":"13","author":"Argil\u00e9s","year":"2013","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"16","key":"10.1002\/14651858.CD012229.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1042\/BCJ20170032","article-title":"Novel targeted therapies for cancer cachexia","volume":"474","author":"Argil\u00e9s","year":"2017","journal-title":"The Biochemical Journal"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0015|cit15","unstructured":"Palliative and Supportive Care Group PaPaS Author and Referee Guidance papas.cochrane.org\/papas-documents"},{"issue":"5","key":"10.1002\/14651858.CD012229.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00520-016-3560-0","article-title":"Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis","volume":"25","author":"Bai","year":"2017","journal-title":"Supportive Care in Cancer"},{"issue":"2","key":"10.1002\/14651858.CD012229.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s13539-011-0031-9","article-title":"Pitfalls in defining and quantifying cachexia","volume":"2","author":"Baracos","year":"2011","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"issue":"5","key":"10.1002\/14651858.CD012229.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/1049909108315518","article-title":"Cytokines and cancer anorexia cachexia syndrome","volume":"25","author":"Bennani-Baiti","year":"2008","journal-title":"American Journal of Hospice & Palliative Care"},{"issue":"4","key":"10.1002\/14651858.CD012229.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0148607108325076","article-title":"Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group","volume":"33","author":"Bozzetti","year":"2009","journal-title":"JPEN. Journal of Parenteral and Enteral Nutrition"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0020|cit20","unstructured":"Centre for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion Health-Related Quality of Life (HRQOL) | CDC www.cdc.gov\/hrqol\/"},{"issue":"31","key":"10.1002\/14651858.CD012229.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.2174\/138161212803216915","article-title":"Ghrelin and motilin in the gastrointestinal system","volume":"18","year":"2012","journal-title":"Current Pharmaceutical Design"},{"issue":"2","key":"10.1002\/14651858.CD012229.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jcsm.12023","article-title":"Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved","volume":"6","author":"Chen","year":"2015","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"issue":"18","key":"10.1002\/14651858.CD012229.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1158\/0008-5472.CAN-15-3152","article-title":"Differential effects of IL6 and activin A in the development of cancer-associated cachexia","volume":"76","author":"Chen","year":"2016","journal-title":"Cancer Research"},{"issue":"4","key":"10.1002\/14651858.CD012229.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/ijms18040798","article-title":"Therapeutic potential of targeting the ghrelin pathway","volume":"18","author":"Colld\u00e9n","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0025|cit25","first-page":"S158","article-title":"Cachexia","volume":"2","author":"Crawford","year":"2015","journal-title":"Journal of Thoracic Oncology"},{"issue":"8","key":"10.1002\/14651858.CD012229.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/diabetes.50.8.1714","article-title":"A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans","volume":"50","author":"Cummings","year":"2001","journal-title":"Diabetes"},{"issue":"1","key":"10.1002\/14651858.CD012229.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.physbeh.2006.05.022","article-title":"Ghrelin and the short- and long-term regulation of appetite and body weight","volume":"89","author":"Cummings David","year":"2006","journal-title":"Physiology & Behavior"},{"issue":"20","key":"10.1002\/14651858.CD012229.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.2217\/fon-2017-0141","article-title":"The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia","volume":"13","author":"Currow","journal-title":"Future Oncology"},{"issue":"4","key":"10.1002\/14651858.CD012229.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/gast.2002.35954","article-title":"The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats","volume":"123","author":"Date","year":"2002","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD012229.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1210\/en.2007-0016","article-title":"Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia","volume":"148","author":"DeBoer","year":"2007","journal-title":"Endocrinology"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0031|cit31","unstructured":"Deeks JJ Higgins JPT Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD012229.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1172\/JCI200421134","article-title":"Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells","volume":"114","author":"Dixit","year":"2004","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1002\/14651858.CD012229.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0034|cit34","unstructured":"Elmagarmid A Fedorowicz Z Hammady H Ilyas I Khabsa M Ouzzani M Rayyan: a systematic reviews web app for exploring and filtering searches for eligible studies for Cochrane Reviews [oral presentation] Cochrane Colloquium John Wiley & Sons 2014"},{"issue":"9","key":"10.1002\/14651858.CD012229.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ctrv.2015.09.002","article-title":"Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist","volume":"41","author":"Esposito","year":"2015","journal-title":"Cancer Treatment Reviews"},{"issue":"9","key":"10.1002\/14651858.CD012229.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.2337\/diabetes.52.9.2260","article-title":"Hyperphagic effects of brainstem ghrelin administration","volume":"52","author":"Faulconbridge","year":"2003","journal-title":"Diabetes"},{"issue":"6","key":"10.1002\/14651858.CD012229.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"The American Journal of Clinical Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD012229.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012229.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metabolism"},{"issue":"Pt 1","key":"10.1002\/14651858.CD012229.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1113\/jphysiol.2003.040600","article-title":"Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats","volume":"550","author":"Fujino","year":"2003","journal-title":"The Journal of Physiology"},{"issue":"9","key":"10.1002\/14651858.CD012229.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.biopsych.2008.10.031","article-title":"Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin","volume":"65","author":"Fujitsuka","year":"2009","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1038\/tp.2011.25","article-title":"Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival","volume":"1","author":"Fujitsuka","year":"2011","journal-title":"Translational Psychiatry"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fphar.2014.00271","article-title":"Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome","volume":"5","author":"Fujitsuka","year":"2014","journal-title":"Frontiers in Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD012229.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.mehy.2015.09.008","article-title":"A hypothesis for a possible synergy between ghrelin and exercise in patients with cachexia: biochemical and physiological bases","volume":"85","author":"Fuoco","year":"2015","journal-title":"Medical Hypotheses"},{"issue":"5","key":"10.1002\/14651858.CD012229.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1210\/jc.2004-1788","article-title":"Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia","volume":"90","author":"Garcia","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"18S","key":"10.1002\/14651858.CD012229.pub2-BIB0046|cit46","first-page":"9133","article-title":"A phase II randomized, placebo-controlled, double-blind study of the efficacy and safety of RC-1291 (RC) for the treatment of cancer cachexia","volume":"25","author":"Garcia","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012229.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ghir.2008.12.003","article-title":"Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers","volume":"19","author":"Garcia","year":"2009","journal-title":"Growth Hormone & IGF Research"},{"issue":"1","key":"10.1002\/14651858.CD012229.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00520-012-1500-1","article-title":"Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study","volume":"21","author":"Garcia","year":"2013","journal-title":"Supportive Care in Cancer"},{"issue":"1","key":"10.1002\/14651858.CD012229.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1470-2045(14)71154-4","article-title":"Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials","volume":"16","author":"Garcia","year":"2015","journal-title":"Lancet Oncology"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0050|cit50","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"issue":"2","key":"10.1002\/14651858.CD012229.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1210\/endo.142.2.7987","article-title":"Ghrelin, a novel placental-derived hormone","volume":"142","author":"Gualillo","year":"2001","journal-title":"Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD012229.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.mehy.2006.08.022","article-title":"Ghrelin may reduce radiation-induced mucositis and anorexia in head-neck cancer","volume":"68","author":"Guney","year":"2007","journal-title":"Medical Hypotheses"},{"issue":"4","key":"10.1002\/14651858.CD012229.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/jcsm.12084","article-title":"Novel mechanism of ghrelin therapy for cachexia","volume":"6","author":"Hatanaka","year":"2015","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0054|cit54","unstructured":"Higgins JPT Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0055|cit55","unstructured":"Higgins JPT Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0056|cit56","unstructured":"Randomised phase I\/II - study with ghrelin versus placebo for patients with cancer-related anorexia\/cachexia ISRCTN registry 10.1186\/ISRCTN26185223"},{"issue":"10","key":"10.1002\/14651858.CD012229.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.biocel.2013.05.032","article-title":"Muscle wasting in cancer","volume":"45","author":"Johns","year":"2013","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"4","key":"10.1002\/14651858.CD012229.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"425","DOI":"10.5455\/ijmsph.2014.250120141","article-title":"Role of ghrelin in regulation of growth hormone secretion by ghrelin-pituitary-GH axis","volume":"3","author":"Khatib","year":"2014","journal-title":"International Journal of Medical Science and Public Health"},{"issue":"3","key":"10.1002\/14651858.CD012229.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/1995-705X.144792","article-title":"Cardioprotective effects of ghrelin in heart failure: from gut to heart","volume":"15","author":"Khatib","year":"2014","journal-title":"Heart Views"},{"issue":"3","key":"10.1002\/14651858.CD012229.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5455\/njppp.2014.4.230420141","article-title":"Ghrelin for regulating appetite and energy balance: a systematic review","volume":"4","author":"Khatib","year":"2014","journal-title":"National Journal of Physiology, Pharmacy and Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012229.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/1755-6783.145008","article-title":"Somatotropic and cardio-protective effects of ghrelin in experimental models of heart failure: a systematic review","volume":"7","author":"Khatib","year":"2014","journal-title":"Annals of Tropical Medicine and Public Health"},{"issue":"6","key":"10.1002\/14651858.CD012229.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"756","DOI":"10.5455\/ijmsph.2014.060420141","article-title":"Cardiovascular effects of ghrelin in heart failure: a systematic review","volume":"3","author":"Khatib","year":"2014","journal-title":"International Journal of Medical Science and Public Health"},{"issue":"8","key":"10.1002\/14651858.CD012229.pub2-BIB0063|cit63","first-page":"MC13","article-title":"Ghrelin: ghrelin as a regulatory peptide in growth hormone secretion","volume":"8","author":"Khatib","year":"2014","journal-title":"Journal of Clinical and Diagnostic Research"},{"issue":"5","key":"10.1002\/14651858.CD012229.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"e0126697","DOI":"10.1371\/journal.pone.0126697","article-title":"Effect of ghrelin on mortality and cardiovascular outcomes in experimental rat and mice models of heart failure: a systematic review and meta-analysis","volume":"10","author":"Khatib","year":"2015","journal-title":"PloS One"},{"issue":"2","key":"10.1002\/14651858.CD012229.pub2-BIB0065|cit65","first-page":"LE01","article-title":"Ghrelin-O-acyl-transferase (GOAT) as a novel metabolic regulatory enzyme","volume":"9","author":"Khatib","year":"2015","journal-title":"Journal of Clinical and Diagnostic Research"},{"issue":"1","key":"10.1002\/14651858.CD012229.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1467-789X.2006.00270.x","article-title":"The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review","volume":"8","author":"Klok","year":"2007","journal-title":"Obesity Reviews"},{"issue":"6762","key":"10.1002\/14651858.CD012229.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/400_2007_049","article-title":"Structure and function of ghrelin","volume":"46","author":"Kojima","year":"2008","journal-title":"Results and Problems in Cell Differentiation"},{"issue":"2","key":"10.1002\/14651858.CD012229.pub2-BIB0069|cit69","first-page":"881","article-title":"The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors","volume":"86","author":"Korbonits","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD012229.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2265.2008.03321.x","article-title":"Ghrelin and the differential regulation of des-acyl (DSG) and oct-anoyl ghrelin (OTG) in human adipose tissue (AT)","volume":"70","author":"Kos","year":"2009","journal-title":"Clinical Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD012229.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/187221411794351897","article-title":"Ghrelin, a novel peptide hormone in the regulation of energy balance and cardiovascular function","volume":"5","author":"Ledderose","year":"2011","journal-title":"Recent Patents on Endocrine, Metabolic & Immune Drug Discovery"},{"issue":"1","key":"10.1002\/14651858.CD012229.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbcan.2017.02.002","article-title":"Ghrelin and cancer progression","volume":"1868","author":"Hsiao","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"issue":"17","key":"10.1002\/14651858.CD012229.pub2-BIB0073|cit73","first-page":"30427","article-title":"Biomarkers of cancer cachexia","volume":"pii: S0009-9120","author":"Loumaye","year":"2017","journal-title":"Clinical Biochemistry"},{"issue":"3","key":"10.1002\/14651858.CD012229.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1615\/CritRevOncog.v17.i3.90","article-title":"Cancer cachexia: from molecular mechanisms to patient's care","volume":"17","author":"Lucia","year":"2012","journal-title":"Critical Reviews in Oncogenesis"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0075|cit75","doi-asserted-by":"crossref","unstructured":"Madeddu C Mantovani G Gramignano G Astara G Maccio A Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches Future Oncology 2015 [Epub ahead of print] 26376740","DOI":"10.2217\/fon.15.195"},{"issue":"14","key":"10.1002\/14651858.CD012229.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1517\/14656566.2015.1079621","article-title":"Advances in pharmacologic strategies for cancer cachexia","volume":"16","author":"Madeddu","year":"2015","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"3","key":"10.1002\/14651858.CD012229.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1006\/bbrc.2000.3568","article-title":"Ghrelin stimulates gastric acid secretion and motility in rats","volume":"276","author":"Masuda","year":"2000","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10.1002\/14651858.CD012229.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1530\/JOE-15-0170","article-title":"Molecular and neuroendocrine mechanisms of cancer cachexia","volume":"226","author":"Mendes","year":"2015","journal-title":"Journal of Endocrinology"},{"issue":"7","key":"10.1002\/14651858.CD012229.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012229.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MCO.0000000000000075","article-title":"Ghrelin: from discovery to cancer cachexia therapy","volume":"17","author":"Molfino","year":"2014","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"issue":"3","key":"10.1002\/14651858.CD012229.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-5793(00)02308-5","article-title":"Kidney produces a novel acylated peptide, ghrelin","volume":"486","author":"Mori","year":"2000","journal-title":"FEBS Letters"},{"issue":"2","key":"10.1002\/14651858.CD012229.pub2-BIB0082|cit82","first-page":"320","article-title":"MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism","volume":"83","author":"Murphy","year":"1998","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"6","key":"10.1002\/14651858.CD012229.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"437-60","DOI":"10.1016\/j.molmet.2015.03.005","article-title":"Ghrelin","volume":"4","author":"M\u00fcller","year":"2015","journal-title":"Mol Metab"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0084|cit84","unstructured":"National Cancer Institute Cancer Trends Progress Report progressreport.cancer.gov"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0085|cit85","unstructured":"Ghrelin - a possible opportunity to improve appetite (phase 3) ClinicalTrials.gov 2008"},{"issue":"9","key":"10.1002\/14651858.CD012229.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1007\/s00520-013-1800-0","article-title":"Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model","volume":"21","author":"Northrup","year":"2013","journal-title":"Supportive Care in Cancer"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0087|cit87","volume-title":"StatPearls","author":"Ohnuma","year":"2017"},{"issue":"10","key":"10.1002\/14651858.CD012229.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"e13604","DOI":"10.1371\/journal.pone.0013604","article-title":"Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition","volume":"5","author":"Penna","year":"2010","journal-title":"PloS one"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.semcdb.2015.09.002","article-title":"Experimental cancer cachexia: evolving strategies for getting closer to the human scenario","volume":"54","author":"Penna","year":"2016","journal-title":"Seminars in Cell and Developmental Biology"},{"issue":"4","key":"10.1002\/14651858.CD012229.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13539-014-0159-5","article-title":"Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile","volume":"5","author":"Pietra","year":"2014","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"issue":"2","key":"10.1002\/14651858.CD012229.pub2-BIB0091|cit91","first-page":"611","article-title":"Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice","volume":"123","author":"Porporato","year":"2013","journal-title":"The Journal of Clinical Investigation"},{"issue":"4","key":"10.1002\/14651858.CD012229.pub2-BIB0092|cit92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008664.pub2","article-title":"Thalidomide for managing cancer cachexia","author":"Reid","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0093|cit93","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0094|cit94","doi-asserted-by":"crossref","unstructured":"Ryan AM Power DG Daly L Cushen SJ Ni Bhuachalla E Prado CM Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later Nutrition Society 2016 1 13 26786393","DOI":"10.1017\/S002966511500419X"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0095|cit95","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"9","key":"10.1002\/14651858.CD012229.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"R393","DOI":"10.1530\/ERC-16-0130","article-title":"Is there an effect of ghrelin\/ghrelin analogs on cancer? A systematic review","volume":"23","author":"Sever","year":"2016","journal-title":"Endocrine-Related Cancer"},{"issue":"9","key":"10.1002\/14651858.CD012229.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"e12729","DOI":"10.1371\/journal.pone.0012729","article-title":"Ghrelin is produced in taste cells and ghrelin receptor null mce show reduced taste responsivity to salty (NaCl) and sour (citric acid) tastants","volume":"5","author":"Martin","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1002\/14651858.CD012229.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/SPC.0b013e3283186be2","article-title":"Cachexia, survival and the acute phase response","volume":"2","author":"Stephens","year":"2008","journal-title":"Current Opinion in Supportive and Palliative Care"},{"issue":"2","key":"10.1002\/14651858.CD012229.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"140","DOI":"10.7861\/clinmedicine.6-2-140","article-title":"Cancer cachexia and fatigue","volume":"6","author":"Stewart","year":"2006","journal-title":"Clinical Medicine"},{"issue":"1-3","key":"10.1002\/14651858.CD012229.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.regpep.2012.06.003","article-title":"Ghrelin improves body weight loss and skeletal muscle catabolism associated with angiotensin II-induced cachexia in mice","volume":"178","author":"Sugiyama","year":"2012","journal-title":"Regulatory Peptides"},{"issue":"7","key":"10.1002\/14651858.CD012229.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/01635581.2015.1073753","article-title":"An epidemiological survey of cachexia in advanced cancer patients and analysis on its diagnostic and treatment status","volume":"67","author":"Sun","year":"2015","journal-title":"Nutrition and Cancer"},{"issue":"5","key":"10.1002\/14651858.CD012229.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1507\/endocrj.K10E-077","article-title":"The role of gut hormones and the hypothalamus in appetite regulation","volume":"57","author":"Suzuki","year":"2010","journal-title":"Endocrine Journal"},{"issue":"7","key":"10.1002\/14651858.CD012229.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1053\/j.gastro.2008.02.078","article-title":"Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism","volume":"134","author":"Takeda","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD012229.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012229.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpainsymman.2006.10.015","article-title":"Symptom prevalence in patients with incurable cancer: a systematic review","volume":"34","author":"Teunissen","year":"2007","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD012229.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiological Reviews"},{"issue":"6806","key":"10.1002\/14651858.CD012229.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/35038090","article-title":"Ghrelin induces adiposity in rodents","volume":"407","author":"Tschop","year":"2000","journal-title":"Nature"},{"key":"10.1002\/14651858.CD012229.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2014.09.025","article-title":"Ghrelin relieves cancer cachexia associated with the development of lung adenocarcinoma in mice","volume":"743","author":"Tsubouchi","year":"2014","journal-title":"European Journal of Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012229.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s13539-012-0075-5","article-title":"Predicting survival in cancer patients: the role of cachexia and hormonal, nutritional and inflammatory markers","volume":"3","author":"Utech","year":"2012","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"issue":"3","key":"10.1002\/14651858.CD012229.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/er.2002-0029","article-title":"Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin","volume":"25","author":"Van der Lely","year":"2004","journal-title":"Endocrine Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012229.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/bjp.2008.153","article-title":"Regulation of muscle mass by growth hormone and IGF-I","volume":"154","author":"Velloso","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012229.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1210\/jcem.87.3.8279","article-title":"Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors","volume":"87","author":"Volante","year":"2002","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD012229.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijcard.2012.09.213","article-title":"Cachexia as major underestimated unmet medical need: facts and numbers","volume":"161","author":"Haehling","year":"2012","journal-title":"International Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD012229.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0889-8588(05)70334-8","article-title":"Anorexia and cachexia, asthenia, and lethargy","volume":"10","author":"Watanabe","year":"1996","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"2","key":"10.1002\/14651858.CD012229.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00000658-198808000-00013","article-title":"Risk factors for postoperative pneumonia. The importance of protein depletion","volume":"208","author":"Windsor","year":"1988","journal-title":"Annals of Surgery"},{"issue":"12","key":"10.1002\/14651858.CD012229.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1210\/jcem.86.12.8111","article-title":"Ghrelin enhances appetite and increases food intake in humans","volume":"86","author":"Wren","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD012229.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1159\/000107549","article-title":"Ghrelin stimulates myocyte development","volume":"20","author":"Zhang","year":"2007","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"8","key":"10.1002\/14651858.CD012229.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1517\/14656566.2015.1041500","article-title":"Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC","volume":"16","author":"Zhang","year":"2015","journal-title":"Expert Opinion on Pharmacotherapy"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012229.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T23:04:20Z","timestamp":1628550260000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012229.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,28]]},"references-count":118,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012229.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,28]]}}}